Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;9(5):314-6.

Management of anemia in patients receiving triple therapy for hepatitis C

A Sidney Barritt 4th  1
Affiliations

Management of anemia in patients receiving triple therapy for hepatitis C

A Sidney Barritt 4th. Gastroenterol Hepatol (N Y). 2013 May.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Barritt AS, IV, Fried MW. Maximizing opportunities and avoiding mistakes in triple therapy for HCV. Gastroenterology. 2012;142:1314–1323-e1.. - PMC - PubMed
    1. Hitomi Y, Cirulli ET, Fellay J, et al. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. Gastroenterology. 2011;140:1314–1321. - PubMed
    1. Kwo PY, Lawitz EJ, McCone J, et al. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial. Lancet. 2010;376:705–716. - PubMed
    1. Mancino P, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J. Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. MediterrJHematolInfect Dis. 2010;2 e2010003. - PMC - PubMed
    1. Thompson AJ, Santoro R, Piazzolla V, et al. Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR. Hematology. 2011;53:389–395. - PMC - PubMed

LinkOut - more resources